ACE2 and COVID-19: SARS-coronavirus 2 (SARS-CoV-2), that leads to the respiratory illness coronavirus disease 2019 (COVID-19), uses its surface envelope Spike glycoprotein (S-protein) to interact and gain access to host cells through the Angiotensin-I converting enzyme-2 (ACE2) receptor.